The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Current anti-diabetic agents and their molecular targets: A review
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
New families in the classification of glycosyl hydrolases based on amino acid sequence similarities
Henrissat, B., & Bairoch, A. (1993) · Biochemical Journal · doi:10.1042/bj2930781 · Cited by 1,974
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., et al. (2003) · Nature · doi:10.1038/nature01478 · Cited by 1,538
Oral Antidiabetic Agents: Current Role in Type 2 Diabetes Mellitus
Krentz, A. J., & Bailey, C. J. (2005) · Drugs · doi:10.2165/00003495-200565030-00005 · Cited by 1,108
The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., Grimaldi, P. A., Kadowaki, T., Lazar, M. A., O’Rahilly, S., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.5 · Cited by 1,000
Thomas, N., K, S., & Kapoor, N. (2016) · A Practical Guide to Diabetes Mellitus · doi:10.5005/jp/books/12651_7 · Cited by 943
Meng, W., Ellsworth, B. A., Nirschl, A. A., McCann, P. J., Patel, M., Girotra, R. N., Wu, G., Sher, P. M., Morrison, E. P., Biller, S. A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701272q · Cited by 634
The role of gut hormones in glucose homeostasis
Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30076 · Cited by 614
Gerich, J. E., Meyer, C., Woerle, H. J., & Stumvoll, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.382 · Cited by 606
Recent advances in understanding the anti-diabetic actions of dietary flavonoids
Babu, P. V. A., Liu, D., & Gilbert, E. R. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.06.003 · Cited by 544
Yabe-Nishimura, C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01347-4 · Cited by 526
Shah, P., Vella, A., Basu, A., Basu, R., Schwenk, W. F., & Rizza, R. A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6993 · Cited by 368
IJpenberg, A., Jeannin, E., Wahli, W., & Desvergne, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20108 · Cited by 352
The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus
Rendell, M. (2004) · Drugs · doi:10.2165/00003495-200464120-00006 · Cited by 308
The role of hyperosmotic stress in inflammation and disease
Brocker, C., Thompson, D. C., & Vasiliou, V. (2012) · bmc · doi:10.1515/bmc-2012-0001 · Cited by 304
Wahli, W., Braissant, O., & Desvergne, B. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90045-4 · Cited by 291
The regulation of protein phosphorylation
Johnson, L. N. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370627 · Cited by 291
Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes
Weber, A. E. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030628v · Cited by 278
Fujiwara, K., Maekawa, F., & Yada, T. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00035.2005 · Cited by 253
Qin, X., Hao, X., Han, H., Zhu, S., Yang, Y., Wu, B., Hussain, S., Parveen, S., Jing, C., Ma, B., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501484b · Cited by 249
Aldose Reductase Enzyme and its Implication to Major Health Problems of the 21st Century
Alexiou, P., Pegklidou, K., Chatzopoulou, M., Nicolaou, I., & Demopoulos, V. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787458362 · Cited by 232
Role of GPR40 in fatty acid action on the β cell line INS-1E
Shapiro, H., Shachar, S., Sekler, I., Hershfinkel, M., & Walker, M. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.042 · Cited by 220
Kazda, C. M., Ding, Y., Kelly, R. P., Garhyan, P., Shi, C., Lim, C. N., Fu, H., Watson, D. E., Lewin, A. J., Landschulz, W. H., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1643 · Cited by 212
THE REGULATION OF PROTEIN PHOSPHORYLATION
Chen, S.-L. (1983) · Purdue e-Pubs (Purdue University System) · Cited by 207
Brubaker, P. L., & Drucker, D. J. (2002) · Receptors and Channels · doi:10.1080/10606820213687 · Cited by 198
Therapeutic significance of β-glucuronidase activity and its inhibitors: A review
Awolade, P., Cele, N., Kerru, N., Gummidi, L., Oluwakemi, E., & Singh, P. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111921 · Cited by 179
Self-citationZhong, Y., Li, J., Chen, Y., Wang, J. J., Ratan, R., & Zhang, S. X. (2012) · Diabetes · doi:10.2337/db11-0315 · Cited by 177
Discovery of a Potent and Selective GPR120 Agonist
Shimpukade, B., Hudson, B. D., Hovgaard, C. K., Milligan, G., & Ulven, T. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300215x · Cited by 162
Therapeutic Approaches to Preserve Islet Mass in Type 2 Diabetes
Baggio, L. L., & Drucker, D. J. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.110104.115624 · Cited by 161
Kakinuma, H., Oi, T., Hashimoto-Tsuchiya, Y., Arai, M., Kawakita, Y., Fukasawa, Y., Iida, I., Hagima, N., Takeuchi, H., Chino, Y., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901893x · Cited by 159
New hepatic targets for glycaemic control in diabetes
Agius, L. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.09.001 · Cited by 155
Ernst, H. A., Leggio, L. L., Willemoës, M., Leonard, G. A., Blum, P., & Larsen, S. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.02.056 · Cited by 143
Imamura, M., Nakanishi, K., Suzuki, T., Ikegai, K., Shiraki, R., Ogiyama, T., Murakami, T., Kurosaki, E., Noda, A., Kobayashi, Y., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.051 · Cited by 139
Zhang, W., Sargis, R. M., Volden, P. A., Carmean, C. M., Sun, X., & Brady, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037103 · Cited by 119
Ottanà, R., Maccari, R., Giglio, M., CORSO, A. D., Cappiello, M., Mura, U., Cosconati, S., Marinelli, L., Novellino, E., Sartini, S., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.03.068 · Cited by 118
Wang, K., Li, B., Ma, K., Zhang, J., Chen, B., Han, J., Ren, J., Luo, H., & Liu, H. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.11.015 · Cited by 111
Kelly, R. P., Garhyan, P., Raddad, E., Fu, H., Lim, C. N., Prince, M. J., Pinaire, J. A., Loh, M. T., & Deeg, M. A. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12446 · Cited by 110
GLP‐1: physiological effects and potential therapeutic applications
Aaboe, K., Krarup, T., Madsbad, S., & Holst, J. J. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00853.x · Cited by 103
Glucagon and Glucagon-Like Peptide Receptors as Drug Targets
Estall, J. L., & Drucker, D. J. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776873671 · Cited by 96
Authier, F., & Desbuquois, B. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7479-6 · Cited by 90
Gómez-Valadés, A. G., Vidal‐Alabró, A., Molas, M., Boada, J., Bermúdez, J., Bartrons, R., & Perales, J. C. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.026 · Cited by 87
Goyard, D., Kónya, B., Chajistamatiou, A. S., Chrysina, E. D., Leroy, J., Balzarin, S., Tournier, M., Tousch, D., Petit, P., Duret, C., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.12.004 · Cited by 86
Negoro, N., Sasaki, S., Mikami, S., Ito, M., Tsujihata, Y., Ito, R., Suzuki, M., Takeuchi, K., Suzuki, N., Miyazaki, J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300170m · Cited by 85
Darwish, K. M., Salama, I., Mostafa, S. M., Gomaa, M. S., & Helal, M. A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.12.049 · Cited by 79
Riaz, S., Khan, I. U., Bajda, M., Ashraf, M., Qurat‐ul‐Ain, Shaukat, A., Rehman, T. U., Mutahir, S., Hussain, S., Mustafa, G., et al. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.09.008 · Cited by 77
Scott, J. S., Birch, A. M., Brocklehurst, K. J., Broo, A., Brown, H. S., Butlin, R. J., Clarke, D. S., Davidsson, Ö., Ertan, A., Goldberg, K., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300310c · Cited by 77
Reddy, T. N., Ravinder, M., Bagul, P. K., Ravikanti, K., Bagul, C., Nanubolu, J. B., Srinivas, K., Banerjee, S., & Rao, V. J. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.043 · Cited by 69
Discovery of furan-2-carbohydrazides as orally active glucagon receptor antagonists
Hasegawa, F., Niidome, K., Migihashi, C., Murata, M., Negoro, T., Matsumoto, T., Kato, K., & Fujii, A. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.07.025 · Cited by 65
Xu, G. Z., Lv, B., Roberge, J. Y., Xu, B., Du, J., Dong, J., Chen, Y., Peng, K., Zhang, L., Tang, X., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401780b · Cited by 65
Glucagon as a target for the treatment of Type 2 diabetes
Sloop, K. W., Michael, M. D., & Moyers, J. S. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.593 · Cited by 64
Glucose‐dependent insulinotropic polypeptide signaling in pancreatic β‐cells and adipocytes
McIntosh, C. H. S., Widenmaier, S. B., & Kim, S. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00196.x · Cited by 64
Oxadiazoles and thiadiazoles: Novel α-glucosidase inhibitors
Kashtoh, H., Hussain, S., Khan, A., Saad, S. M., Khan, J. A., Khan, K. M., Perveen, S., & Choudhary, M. I. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.07.032 · Cited by 63
Dipeptidyl peptidase iv inhibitors and diabetes therapy
McIntosh, C. H. S. (2007) · Frontiers in bioscience · doi:10.2741/2797 · Cited by 62
Li, Z., Qiu, Q., Xu, X. J., Wang, X., Jiao, L., Su, X., Pan, M., Huang, W., & Qian, H. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.040 · Cited by 61
Gao, H.-D., Liu, P., Yang, Y., & Gao, F. (2016) · RSC Advances · doi:10.1039/c6ra15948f · Cited by 59
Christiansen, E., Due‐Hansen, M. E., Urban, C., Grundmann, M., Schröder, R. J., Hudson, B. D., Milligan, G., Cawthorne, M. A., Kostenis, E., Kassack, M. U., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3002026 · Cited by 58
Ottanà, R., Maccari, R., Mortier, J., Caselli, A., Amuso, S., Camici, G., Rotondo, A., Wolber, G., & Paoli, P. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.001 · Cited by 56
Srivastava, J. K., Dubey, P., Singh, S., Bhat, H. R., Kumawat, M. K., & Singh, U. P. (2015) · RSC Advances · doi:10.1039/c4ra16903d · Cited by 55
Blöcher, R., Lamers, C., Wittmann, S. K., Merk, D., Hartmann, M., Weizel, L., Diehl, O., Brüggerhoff, A., Boß, M., Kaiser, A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01239 · Cited by 55
Hyperosmotic stress enhances cytokine production and decreases phagocytosis in vitro
Otto, N., Schindler, R., Lun, A., Boenisch, O., Frei, U. A., & Oppert, M. (2008) · Critical Care · doi:10.1186/cc6989 · Cited by 52
Nomura, S., Yamamoto, Y., Matsumura, Y., Ohba, K., Sakamaki, S., Kimata, H., Nakayama, K., Kuriyama, C., Matsushita, Y., Ueta, K., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400339b · Cited by 52
Yao, C., Song, J., Chen, C., Yeh, T., Hsieh, T.-C., Wu, S., Huang, C.-Y., Huang, Y.-L., Wang, M., Liu, Y.-W., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.06.053 · Cited by 51
Peroxisome Proliferator Activated Receptors
Genolet, R., Michalik, L., & Wahli, W. (2005) · Springer eBooks · doi:10.1007/3-540-27194-5_22 · Cited by 49
Origins and consequences of hyperosmolar stress in retinal pigmented epithelial cells
Willermain, F., Libert, S., Motulsky, E. H., Salik, D., Caspers, L. E., Perret, J., & Delporte, C. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00199 · Cited by 49
Discovery of INT131: A selective PPARγ modulator that enhances insulin sensitivity
Taygerly, J. P., McGee, L. R., Rubenstein, S. M., Houze, J. B., Cushing, T. D., Li, Y., Motani, A. S., Chen, J., Frankmoelle, W. P., Ye, G., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.11.058 · Cited by 49
Morris, L. C., Nance, K. D., Gentry, P. R., Days, E., Weaver, C. D., Niswender, C. M., Thompson, A. D., Jones, C. K., Locuson, C. W., Morrison, R. D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501375c · Cited by 49
Wacker, D. A., Wang, Y., Broekema, M., Rossi, K. A., O’Connor, S., Hong, Z., Wu, G. Y., Malmstrom, S. E., Hung, C.-P., LaMarre, L., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501175v · Cited by 48
Verma, S. K., & Thareja, S. (2016) · RSC Advances · doi:10.1039/c6ra03067j · Cited by 47
Fructose-1,6-bisphosphatase genes in animals
Tillmann, H., Bernhard, D., & Eschrich, K. (2002) · Gene · doi:10.1016/s0378-1119(02)00627-3 · Cited by 46
Toda, N., Hao, X., Ogawa, Y., Oda, K., Yu, M., Fu, Z., Chen, Y., Kim, Y., Lizarzaburu, M. E., Lively, S. E., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400186z · Cited by 45
Rattanangkool, E., Kittikhunnatham, P., Damsud, T., Wacharasindhu, S., & Phuwapraisirisan, P. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.05.047 · Cited by 45
Andleeb, H., Tehseen, Y., Shah, S. J. A., Khan, I. A., Iqbal, J., & Hameed, S. (2016) · RSC Advances · doi:10.1039/c6ra14531k · Cited by 45
Ottanà, R., Paoli, P., Naß, A., Lori, G., Cardile, V., Adornato, I., Rotondo, A., Graziano, A. C. E., Wolber, G., & Maccari, R. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.063 · Cited by 45
Robinson, R. P., Mascitti, V., Boustany, C., Carr, C. L., Foley, P. M., Kimoto, E., Leininger, M. T., Lowe, A., Klenotic, M. K., MacDonald, J. I., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.075 · Cited by 44
Jung, C. H., Park, C., Ahn, K. J., Kim, N. H., Jang, H. C., Lee, M., Park, J., Chung, C. H., Min, K., Sung, Y., et al. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2613 · Cited by 43
Guzmán-Pérez, A., Pfefferkorn, J. A., Lee, E. C. Y., Stevens, B. D., Aspnes, G. E., Bian, J., Didiuk, M. T., Filipski, K. J., Moore, D., Perreault, C., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.014 · Cited by 43
Sagar, S. R., Agarwal, J. K., Pandya, D. H., Dash, R. P., Nivsarkar, M., & Vasu, K. K. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.015 · Cited by 42
Kantsadi, A. L., Bokor, É., Kun, S., Stravodimos, G. A., Chatzileontiadou, D. S. M., Leonidas, D. D., Juhász‐Tóth, É., Szakács, A., Batta, G., Docsa, T., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.06.049 · Cited by 42
Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes
Shu, C., Hu, G., Song, M. W., Chen, J.-H., Zhou, H., Qu, Q., Wang, F., Ma, X., Yang, X., Zhang, G., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml5001905 · Cited by 40
Lai, Z., Li, C., Liu, J., Kong, L., Wen, X., & Sun, H. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.044 · Cited by 39
KAZDA, C. M., Frías, J. P., Foga, I., Cui, X., Guzmán, C. B., Garhyan, P., Heilmann, C. R., Yang, J., & Hardy, T. A. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12904 · Cited by 39
Dkhar, B., Khongsti, K., Thabah, D., Syiem, D., Satyamoorthy, K., & Das, B. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26356 · Cited by 39
CP-99,711: a non-peptide glucagon receptor antagonist
Collins, J. L., Dambek, P. J., Goldstein, S. W., & Faraci, W. S. (1992) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)80587-9 · Cited by 38
Ovais, S., Pushpalatha, H., Reddy, G. B., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.046 · Cited by 38
Lizarzaburu, M. E., Turcotte, S., Du, X., Duquette, J., Fu, A., Houze, J. B., Li, L., Liu, J., Murakoshi, M., Oda, K., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.063 · Cited by 36
Small molecule dipeptidylpeptidase IV inhibitors under investigation for diabetes mellitus therapy
Gallwitz, B. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.576667 · Cited by 36
Bie, J., Liu, S., Zhou, J., Xu, B., & Shen, Z. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.01.047 · Cited by 35
Wang, J., Feng, Y., Ji, X., Deng, G., Leng, Y., & Liu, H. S. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.048 · Cited by 34
Li, Z., Pan, M., Su, X., Dai, Y., Fu, M., Cai, X., Shi, W., Huang, W., & Qian, H. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.014 · Cited by 34
Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase
Bie, J., Liu, S., Li, Z., Mu, Y., Xu, B., & Shen, Z. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.049 · Cited by 33
Abdjul, D. B., Yamazaki, H., Kanno, S., Wewengkang, D. S., Rotinsulu, H., Sumilat, D. A., Ukai, K., Kapojos, M. M., & Namikoshi, M. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.01.071 · Cited by 33
Li, Z., Wang, X., Xu, X., Yang, J., Qiu, Q., Qiang, H., Huang, W., & Qian, H. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.09.010 · Cited by 33
Goldenberg, R., Gantz, I., Andryuk, P. J., O’Neill, E. A., Kaufman, K. D., Lai, E., Wang, Y. N., Suryawanshi, S., & Engel, S. S. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12832 · Cited by 32
Ji, X., Xia, C., Wang, J., Su, M., Zhang, L. J., Dong, T., Li, Z., Wan, X., Li, J., Li, J. X., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.08.059 · Cited by 31
Sato, K., Sugimoto, H., Rikimaru, K., Imoto, H., Kamaura, M., Negoro, N., Tsujihata, Y., Miyashita, H., Odani, T., & Murata, T. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.01.028 · Cited by 30
Zhang, R., Yu, R., Qi, X., Li, X., Luo, J., Jiang, B., Wang, L., Guo, S., Wu, N., & Shi, D. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.004 · Cited by 30
Liao, B., He, H., Yang, L., Gao, L., Chang, L., Tang, J., Li, J.-Y., Li, J. X., & Yang, F. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.011 · Cited by 28
Kantsadi, A. L., Manta, S., Psarra, A. G., Dimopoulou, A., Kiritsis, C., Parmenopoulou, V., Skamnaki, V. T., Zoumpoulakis, P. G., Zographos, S. E., Leonidas, D. D., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.06.029 · Cited by 28
Cyclic alpha-conotoxin peptidomimetic chimeras as potent GLP-1R agonists
Swedberg, J. E., Schroeder, C. I., Mitchell, J. M., Durek, T., Fairlie, D. P., Edmonds, D. J., Griffith, D. A., Ruggeri, R. B., Derksen, D. R., Loria, P. M., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.08.046 · Cited by 26
Liu, P., Du, Y., Song, L., Shen, J., & Li, Q. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.04.014 · Cited by 26
Bergman, A. J., Tan, B., Somayaji, V. R., Calle, R. A., & Kazierad, D. J. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.01.019 · Cited by 26
Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors: New among Antidiabetic Drugs
Opie, L. H. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6522-0 · Cited by 25
Pan, X., Huan, Y., Shen, Z., & Liu, Z. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.053 · Cited by 25
Synthesis and biological evaluation of GPR40/FFAR1 agonists containing 3,5-dimethylisoxazole
Yang, L., Zhang, J., Si, L., Han, L., Zhang, B., Ma, H., Xing, J., Zhao, L., Zhou, J., & Zhang, H. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.054 · Cited by 25
Maezaki, H., Tawada, M., Yamashita, T., Banno, Y., Miyamoto, Y., Yamamoto, Y., Ikedo, K., Kosaka, T., Tsubotani, S., Tani, A., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.05.048 · Cited by 25
Zhang, L. J., Chen, X., Liu, J., Zhu, Q., Leng, Y., Luo, X., Jiang, H., & Liu, H. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.06.020 · Cited by 24
Chen, Y.-T., Tang, C., Ma, W.-P., Gao, L., Wei, Y., Zhang, W., Li, J.-Y., Li, J. X., & Nan, F. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.09.017 · Cited by 23
Negoro, K., Yonetoku, Y., Moritomo, A., Hayakawa, M., Iikubo, K., Yoshida, S., Takeuchi, M., & Ohta, M. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.08.054 · Cited by 23
Hansen, S. V. F., Christiansen, E., Urban, C., Hudson, B. D., Stocker, C. J., Due‐Hansen, M. E., Wargent, E. T., Shimpukade, B., Almeida, R., Ejsing, C. S., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01962 · Cited by 22
Li, Z., Wang, X., Xu, X., Yang, J., Xia, W., Zhou, X., Huang, W., & Qian, H. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.10.011 · Cited by 21
Jiang, B., Guo, S., Shi, D., Guo, C., & Wang, T. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.037 · Cited by 21
Chu, K.-F., Yao, C., Song, J., Chen, C., Yeh, T., Hsieh, T.-C., Huang, C.-Y., Wang, M., Wu, S., Chang, W.-E., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.058 · Cited by 21
Liu, P., Du, Y., Song, L., Shen, J., & Li, Q. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.09.024 · Cited by 20
Bajare, S., Anthony, J., Nair, A. S., Marita, R., Damre, A. A., Patel, D. J., B‐Rao, C., Sivaramakrishnan, H., & Deka, N. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.10.027 · Cited by 18
Wilson, J. E., Kurukulasuriya, R., Sinz, C. J., Lombardo, M., Bender, K., Parker, D. L., Sherer, E. C., Costa, M., Dingley, K. H., Li, X., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.04.018 · Cited by 18
Furukawa, A., Arita, T., Fukuzaki, T., Mori, M., Honda, T., Satoh, S., Matsui, Y., Wakabayashi, K., Hayashi, S., Nakamura, K., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.05.040 · Cited by 17
Phosphonate derivatives of tetraazamacrocycles as new inhibitors of protein tyrosine phosphatases
Kobzar, O. L., Shevchuk, M., Lyashenko, A. N., Tanchuk, V. Y., Romanenko, V. D., Kobelev, S. M., Averin, A. D., Beletskaya, I. P., Vovk, A. I., & Kukhar, V. P. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00713e · Cited by 16
Shu, S., Cai, X., Li, J., Feng, Y., Dai, A., Wang, J., Yang, D., Wang, M., & Liu, H. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.04.053 · Cited by 16
Ohtake, Y., Sato, T., Matsuoka, H., Kobayashi, T., Nishimoto, M., Taka, N., Takano, K., Yamamoto, K., Ohmori, M., Higuchi, T., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.04.053 · Cited by 15
Structure and Function of Hepatic Parenchymal Cells*
Devi, S. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01002-2 · Cited by 14
Synthesis, screening and docking of small heterocycles as Glycogen Phosphorylase inhibitors
Schweiker, S. S., Loughlin, W. A., Lohning, A. E., Petersson, M. J., & Jenkins, I. D. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.063 · Cited by 14
Park, Y. H., Choi, H. H., Lee, D. H., Chung, S. Y., Yang, N., Kim, D., Ju, M. K., Han, T., Nam, S. Y., & Kim, K. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0925-y · Cited by 14
Wang, S., Su, M., Wang, J., Li, Z., Zhang, L. J., Ji, X., Li, J., Li, J., & Liu, H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.09.051 · Cited by 13
Mao, S.-W., Shuai, L., He, H., Pan, N., Gao, L., Yu, L.-F., Li, J. X., Li, J.-Y., & Yang, F. (2015) · RSC Advances · doi:10.1039/c5ra20238h · Cited by 13
Small molecule glucagon receptor antagonists: a patent review (2011 – 2014)
Filipski, K. J. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1032250 · Cited by 12
Deora, G. S., Karthikeyan, C., Moorthy, N. S. H. N., Rathore, V., Rawat, A., Tamrakar, A. K., Srivastava, A. K., & Trivedi, P. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0528-1 · Cited by 11
Loughlin, W. A., Jenkins, I. D., Karis, N. D., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.031 · Cited by 11
Chen, J., Sang, Z., Lu, L., He, L., & Ma, L. (2017) · Molecular Diversity · doi:10.1007/s11030-017-9755-6 · Cited by 10
Yang, F., Li, J., Li, J.-Y., He, H., Zhou, Y., Liu, T., Tang, J., Gong, X., & Qiu, W. (2012) · Heterocycles · doi:10.3987/com-12-12565 · Cited by 10
Jain, M. R., Joharapurkar, A. A., Kshirsagar, S. G., Patel, V. J., Bahekar, R. H., Patel, H., Jadav, P. A., Patel, P., & Desai, R. C. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13842 · Cited by 8
Mahapatra, M. K., Kumar, R., Malla, P., & Kumar, M. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0797-8 · Cited by 7
Cited by
A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications
Kerru, N., Gummidi, L., Maddila, S., Gangu, K. K., & Jonnalagadda, S. B. (2020) · Molecules · doi:10.3390/molecules25081909 · Cited by 1,716
Self-citationDiabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
Siti Halimatul Munawaroh, H., Gumilar, G. G., Nurjanah, F., Yuliani, G., Aisyah, S., Kurnia, D., Wulandari, A. P., Kurniawan, I., Ningrum, A., Koyande, A. K., et al. (2020) · Biochemical Engineering Journal · doi:10.1016/j.bej.2020.107666 · Cited by 61
Yoo, S. G., Han, K. D., Lee, K. H., La, Y., Kwon, D. E., & Han, S. H. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0167 · Cited by 32
Metadata
- Authors
- Kerru, N., Singh-Pillay, A., Awolade, P., & Singh, P.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 152
- Pages
- 436-488
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2799603177
- Cited by
- 369
- References
- 133
- FWCI
- 24.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.